Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek® 2026

$GPCRPress releaseOct 19, 2026, 4:13 PM ETRead the release

Structure Therapeutics announced multiple poster presentations at ObesityWeek 2026, taking place November 14-17 in National Harbor, MD. The posters cover aleniglipron (GSBR-1290), the company's oral small-molecule GLP-1 receptor agonist, including ACCESS trial open-label extension data and dose-ranging effects from the ACCESS trials.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.